The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about
the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in …

Substantial variation in the prevalence of dementia in Parkinson's disease (PDD) has been
reported. The aim of this study was to review systematically and critically previous studies of …

Dementia has been increasingly more recognized to be a common feature in patients with
Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of …

A preceding article described the clinical features of Parkinson's disease dementia (PD‐D)
and proposed clinical diagnostic criteria for “probable” and “possible” PD‐D. The main focus …

There are no standardized diagnostic criteria for psychosis associated with Parkinson's
disease (PDPsy). As part of an NIH sponsored workshop, we reviewed the existing literature on …

Given considerable variation in diagnostic and therapeutic practice, there is a need for national
guidance on the use of neuroimaging, fluid biomarkers, cognitive testing, follow-up and …

Background Few longitudinal studies of dementia in Parkinson disease (PD) have been
reported, and the proportion of patients with PD who eventually develop dementia is unknown. …

Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …

Background: In studies of mild cognitive impairment (MCI) in Parkinson disease (PD), patients
without dementia have reported variable prevalences and profiles of MCI, likely to be due …

Dementia is a frequent problem encountered in advanced stages of Parkinson disease (PD).
In recent years, research has focused on the pre-dementia stages of cognitive impairment …